Advertisement Cellectis develops VizuCELL cell lines for biomedical research, cell biology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cellectis develops VizuCELL cell lines for biomedical research, cell biology

Cellectis bioresearch, a subsidiary of Cellectis, has developed VizuCELL cell lines for biomedical research and cell biology.

The company developed VizuCELL cell lines as a tool to study temporal and spatial dynamic processes in living cells.

The tool provides insights into morphological changes and physiological events within the cell.

TALEN technology will be used to generate VizuCELL that tags to endogenous genes with a fluorescent signal controlled by the endogenous promoter.

The VizuCELL product line comprises HeLa and U-2 OS enabling unambiguous visualization of cell organelles and the cytoskeleton.

VizuCELL features stable endogenous protein expression and is suitable for non-invasive long-term monitoring.